Compare Stocks → The Next Step of Their Control Is Here … (From Weiss Ratings) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:DNPNASDAQ:IBB Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDNPDNP Select Income Fund$8.84$8.90$8.09▼$11.18$3.14B0.47625,649 shs396,538 shsIBBiShares Biotechnology ETF$126.49+0.7%$134.67$111.83▼$141.16$7.03B0.731.80 million shs833,029 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDNPDNP Select Income Fund+0.11%+0.74%-2.64%-0.11%-15.81%IBBiShares Biotechnology ETF-1.64%+0.83%-7.51%-7.15%-2.38%Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDNPDNP Select Income FundN/AN/AN/AN/AN/AN/AN/AN/AIBBiShares Biotechnology ETFN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDNPDNP Select Income FundN/AN/AN/AN/AIBBiShares Biotechnology ETF0.00N/A$155.4322.88% UpsideCurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDNPDNP Select Income FundN/AN/AN/AN/AN/AN/AIBBiShares Biotechnology ETFN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDNPDNP Select Income FundN/AN/A0.00∞N/AN/AN/AN/A6/28/2024 (Estimated)IBBiShares Biotechnology ETFN/AN/A0.00∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDNPDNP Select Income Fund$0.788.82%N/AN/AN/AIBBiShares Biotechnology ETF$0.410.32%N/AN/AN/ALatest IBB and DNP DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/20/2024DNPDNP Select Income Fund--$0.06508.6%6/28/20246/28/20247/10/20243/19/2024DNPDNP Select Income Fund--$0.06508.6%5/31/20245/31/20246/10/20243/15/2024DNPDNP Select Income FundMonthly$0.06508.6%4/29/20244/30/20245/10/20243/20/2024IBBiShares Biotechnology ETFQuarterly$0.12603/21/20243/22/20243/27/20241/30/2024DNPDNP Select Income Fund$0.06508.62%1/30/20241/31/20242/12/2024(Data available from 1/1/2013 forward)OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDNPDNP Select Income Fund8.51%IBBiShares Biotechnology ETF62.45%Insider OwnershipCompanyInsider OwnershipDNPDNP Select Income Fund0.06%IBBiShares Biotechnology ETFN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableDNPDNP Select Income FundN/A354.86 million354.64 millionNot OptionableIBBiShares Biotechnology ETFN/A55.55 millionN/AOptionableIBB and DNP HeadlinesSourceHeadline9 Best Biotech ETFs for 2024msn.com - April 19 at 1:16 PMIBB Crosses Critical Technical Indicatornasdaq.com - April 17 at 8:39 AMTop 10 best performing S&P 500 health care stocks of 2024msn.com - April 10 at 5:33 PMSemiconductors Steady, Biotech Stumbles: What's Next for These Sectors?investing.com - April 8 at 9:46 AMWhat's Next For Rangebound Stock Market ETFs?seeitmarket.com - April 5 at 10:28 AMIs iShares Biotechnology ETF (IBB) a Strong ETF Right Now?zacks.com - April 5 at 7:21 AMBiotech Sector Nears Breakout: Will it Outperform in Q2?marketbeat.com - April 3 at 6:11 AMBiotech Sector Nears Breakout: Will it Outperform in Q2? (IBB)marketbeat.com - April 3 at 6:10 AMYields Up, US Dollar Up, Junk Bonds Tumble as New Quarter Kicks Offinvesting.com - April 2 at 4:26 AMDon't Be Fooled By 5 Top-Ranked ETFs' Q1 Underperformanceszacks.com - April 1 at 2:00 PMPBE: Biotech Could Be Next Big Winnerseekingalpha.com - April 1 at 1:23 PMAre Retail Stocks Poised for Further Gains?investing.com - April 1 at 8:23 AM2 Top Biotech Buyout Candidateszacks.com - March 28 at 2:56 PMShould You Invest in the iShares Biotechnology ETF (IBB)?zacks.com - March 28 at 7:21 AMIBB: Let It Restseekingalpha.com - March 26 at 4:46 AMiShares Nasdaq Biotechnology ETF declares quarterly distribution of $0.1259msn.com - March 24 at 1:43 PMHow to Find Up-and-Coming Stocks to Buy Right Nowzacks.com - March 19 at 3:01 PM3 Biotech ETFs Overdue for a Bounceinvestorplace.com - March 19 at 2:45 PMIBB Apr 2024 139.500 callfinance.yahoo.com - March 18 at 7:27 AMIBB Apr 2024 131.000 putfinance.yahoo.com - March 18 at 7:27 AMSilver, Gold Poised for Breakout? Key Levels to Watch for Confirmationinvesting.com - March 18 at 3:54 AMIBB Apr 2024 136.500 callfinance.yahoo.com - March 18 at 3:10 AMTwo Different Flavors of Biotechmsn.com - March 16 at 4:10 PMIBB Mar 2024 145.000 callfinance.yahoo.com - March 16 at 2:23 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsDNP Select Income FundNYSE:DNPDNP Select Income Fund Inc. is a closed ended balanced mutual fund launched by Virtus Investment Partners, Inc. The fund is managed by Duff & Phelps Investment Management Co. It invests in the public equity and fixed income markets of the United States. For the fixed income portion, the fund invests in bonds. It seeks to invest in stocks of companies operating in the Utility sector. The fund invests in stocks of companies across all market capitalizations. It benchmarks the performance of its portfolio against the S&P 500 Utilities Index and Barclays Capital U.S. Utility Bond Index. DNP Select Income Fund Inc. was formed on November 26, 1986 and is domiciled in the United States.iShares Biotechnology ETFNASDAQ:IBBiShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
